Design of the Tocilizumab in Giant Cell Arteritis Trial

Design of the Tocilizumab in Giant Cell Arteritis Trial

Overview. The GiACTA trial is a multicenter, randomized, double-blind, and placebo-controlled study designed to test the ability of tocilizumab (TCZ), an interleukin (IL)-6 receptor antagonist, to maintain disease remission in patients with giant cell arteritis (GCA). Design. Approximately 100 cente...

Full description

Bibliographic Details
Main Authors:	Sebastian H. Unizony, Bhaskar Dasgupta, Elena Fisheleva, Lucy Rowell, Georg Schett, Robert Spiera, Jochen Zwerina, Olivier Harari, John H. Stone
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	International Journal of Rheumatology
Online Access:	http://dx.doi.org/10.1155/2013/912562

Similar Items

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
by: Sebastian Unizony, et al.
Published: (2021-01-01)

Profile of tocilizumab and its potential in the treatment of giant cell arteritis
by: Mollan SP, et al.
Published: (2018-01-01)

Vision loss in patients with giant cell arteritis treated with tocilizumab
by: Jennifer Amsler, et al.
Published: (2021-03-01)

Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
by: Vibeke Strand, et al.
Published: (2019-02-01)

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
by: Sara Gale, et al.
Published: (2019-02-01)

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis
by: Maxime Samson, et al.
Published: (2021-01-01)

The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial
by: Choi, H.K, et al.
Published: (2022)

Tocilizumab, an interleukin-6 inhibitor: a steroid sparing agent in giant cell arteritis
by: P Jobanputra, et al.
Published: (2017-09-01)

Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report
by: Michaela Butryn, et al.
Published: (2021-06-01)

Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
by: Hubert de Boysson, et al.
Published: (2021-05-01)

Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool
by: Bhaskar Dasgupta, et al.
Published: (2020-11-01)

EXPERIENCE WITH TOCILIZUMAB, AN INTERLEUKIN 6 INHIBITOR, USED FOR THE TREATMENT OF GIANT CELL ARTERITIS WITH SEVERE COMORBIDITY
by: T. V. Beketova, et al.
Published: (2018-05-01)

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis
by: Edoardo Conticini, et al.
Published: (2020-01-01)

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
by: Wolfgang A. Schmidt, et al.
Published: (2020-08-01)

Giant cell arteritis: a review
by: Patil P, et al.
Published: (2013-03-01)

Tocilizumab throughout pregnancy in two patients with severe Takayasu’s arteritis
by: Ana Rita Cruz-Machado, et al.
Published: (2021-04-01)

Takayasu arteritis of atypical presentation. Tocilizumab as an alternative therapeutic option
by: Zaira Cubiles Arillo, et al.
Published: (2019-12-01)

Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial
by: Arsene Mekinian, et al.
Published: (2020-09-01)

Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database
by: Jennie H. Best, et al.
Published: (2019-10-01)

Giant Cell Arteritis
by: Bruno Coulier, et al.
Published: (2018-01-01)

Giant cell arteritis
by: GC Colin, et al.
Published: (2013-09-01)

Giant-Cell Arteritis
Published: (2022)

Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody
by: Alfredomaria Lurati, et al.
Published: (2012-01-01)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
by: Pavlos Stamatis
Published: (2020-01-01)

Utility and safety of tocilizumab in Takayasu arteritis with severe heart failure and muscle wasting
by: Toshiyuki Yano, et al.
Published: (2019-08-01)

Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis
by: A. Lo Gullo, et al.
Published: (2017-12-01)

Arteritis de Takayasu de presentación atípica. Tocilizumab como alternativa terapéutica
by: Zaira Cubiles Arillo, et al.
Published: (2019-12-01)

Perioperative Management of Takayasu Arteritis for Cardiac Surgery in a Patient Treated With Tocilizumab
by: Yoh Arita, MD, PhD, et al.
Published: (2020-12-01)

Giant Cell Arteritis of the Breast
by: Nur BÜYÜKPINARBAŞILI, et al.
Published: (2015-12-01)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
by: Anne Claire Desbois, et al.
Published: (2021-03-01)

Innate and Adaptive Immunity in Giant Cell Arteritis
by: Mitsuhiro Akiyama, et al.
Published: (2021-02-01)

New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review
by: Rosaria Del Giorno, et al.
Published: (2019-04-01)

Biologic Therapies for Giant Cell Arteritis
by: Harrington R, et al.
Published: (2021-01-01)

Doppler ultrasound and giant cell arteritis
by: Ana Marina Suelves, et al.
Published: (2010-11-01)

An Unusual Presentation of Giant Cell Arteritis
by: Siddhesh Prabhavalkar, et al.
Published: (2012-01-01)

Macrophage phenotypes in giant cell arteritis
by: Graham, Amy Eve
Published: (2018)

Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
by: Diana Prieto-Peña, et al.
Published: (2021-06-01)

Clinical Images: Pulmonary Arteritis in Clinically Occult Aneurysmal Giant Cell Arteritis
by: Victoria L Johnson, et al.
Published: (2021-05-01)

Giant cell arteritis: proven and debatable aspects of treatment
by: А.N. Lyzikov, et al.
Published: (2020-02-01)

Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis
by: Yannick van Sleen, et al.
Published: (2017-07-01)

Cannot write session to /tmp/vufind_sessions/sess_g57ro9di4cpfobkro7meb7uj7q